Related Experiment Video
Updated: Jun 21, 2025
10:09
Transtubular Endoscopic Posterolateral Decompression for L5-S1 Lumbar Lateral Disc Herniation
Published on: October 14, 2022
3.8K
Thoracic Intervertebral Disc Herniation Associated With Chronic Anabolic Androgenic Steroid Use: A Case Report
Nathaniel A Cleri1, Jason Zhang1, Gurinder Singh2
1Neurosurgery, Stony Brook University, Stony Brook, USA.
Cureus
|July 16, 2024
Summary
Anabolic androgenic steroids (AAS) increase musculoskeletal injury risk. Chronic AAS use in bodybuilders can lead to severe conditions like spinal disc herniation, requiring surgical intervention.
Area of Science:
- Sports Medicine
- Orthopedics
- Endocrinology
Background:
- Anabolic androgenic steroids (AAS) are widely used for performance enhancement and muscle growth.
- Despite known risks like tendon ruptures, self-administration in high doses persists.
- AAS use is linked to various detrimental health effects.
Observation:
- A case study of a male bodybuilder with chronic AAS use is presented.
- The individual developed a thoracic intervertebral disc herniation.
- This condition necessitated surgical decompression and fusion.
Findings:
- Chronic AAS abuse, particularly with weight-bearing exercise, elevates the risk of severe musculoskeletal injuries.
- Intervertebral disc herniation is a potential, severe consequence of supraphysiologic AAS dosing.
- Biochemical, physical, and physiological mechanisms link AAS use to spinal injury.
Implications:
- Highlights a severe, under-recognized risk of chronic AAS abuse in athletes and bodybuilders.
- Suggests the need for increased awareness and screening for spinal injuries in AAS users.
- Underscores the importance of understanding the complex interplay between AAS, exercise, and musculoskeletal health.
Related Concept Videos
01:27Pneumothorax-II
137
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
137
01:29Pulmonary Tuberculosis I
231
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
01:26Pneumothorax-I
190
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
190